1
|
Brown KT and Covey AM: Management of
malignant biliary obstruction. Tech Vasc Interv Radiol. 11:43–50.
2008. View Article : Google Scholar : PubMed/NCBI
|
2
|
Saluja SS, Gulati M, Garg PK, et al:
Endoscopic or percutaneous biliary drainage for gallbladder cancer:
a randomized trial and quality of life assessment. Clin
Gastroenterol Hepatol. 6:944–950. 2008. View Article : Google Scholar : PubMed/NCBI
|
3
|
Kloek JJ, van der Gaag NA, Aziz Y, et al:
Endoscopic and percutaneous preoperative biliary drainage in
patients with suspected hilar cholangiocarcinoma. J Gastrointest
Surg. 14:119–125. 2010. View Article : Google Scholar : PubMed/NCBI
|
4
|
Piñol V, Castells A, Bordas JM, et al:
Percutaneous self-expanding metal stents versus endoscopic
polyethylene endoprostheses for treating malignant biliary
obstruction: randomized clinical trial. Radiology. 225:27–34.
2002.
|
5
|
Laméris JS, Obertop H and Jeekel J:
Biliary drainage by ultrasound-guided puncture of the left hepatic
duct. Clin Radiol. 36:269–274. 1985.PubMed/NCBI
|
6
|
Lammer J, Hausegger KA, Flückiger F, et
al: Common bile duct obstruction due to malignancy: treatment with
plastic versus metal stents. Radiology. 201:167–172. 1996.
View Article : Google Scholar : PubMed/NCBI
|
7
|
Knyrim K, Wagner HJ, Pausch J and Vakil N:
A prospective, randomized, controlled trial of metal stents for
malignant obstruction of the common bile duct. Endoscopy.
25:207–212. 1993. View Article : Google Scholar : PubMed/NCBI
|
8
|
Lee SH, Park JK, Yoon WJ, et al: Optimal
biliary drainage for inoperable Klatskin’s tumor based on Bismuth
type. World J Gastroenterol. 13:3948–3955. 2007.PubMed/NCBI
|
9
|
Silva MA, Tekin K, Aytekin F, Bramhall SR,
Buckels JA and Mirza DF: Surgery for hilar cholangiocarcinoma; a 10
year experience of a tertiary referral centre in the UK. Eur J Surg
Oncol. 31:533–539. 2005.PubMed/NCBI
|
10
|
Mansfield SD, Barakat O, Charnley RM, et
al: Management of hilar cholangiocarcinoma in the North of England:
pathology, treatment, and outcome. World J Gastroenterol.
11:7625–7630. 2005.PubMed/NCBI
|
11
|
Singhal D, van Gulik TM and Gouma DJ:
Palliative management of hilar cholangiocarcinoma. Surg Oncol.
14:59–74. 2005. View Article : Google Scholar : PubMed/NCBI
|
12
|
Larssen L, Medhus AW, Hjermstad MJ, et al:
Patient-reported outcomes in palliative gastrointestinal stenting:
a Norwegian multicenter study. Surg Endosc. 25:3162–3169. 2011.
View Article : Google Scholar : PubMed/NCBI
|
13
|
Ho CS and Warkentin AE: Evidence-based
decompression in malignant biliary obstruction. Korean J Radiol.
13:S56–S61. 2012. View Article : Google Scholar : PubMed/NCBI
|
14
|
Paik WH, Park YS, Hwang JH, et al:
Palliative treatment with self-expandable metallic stents in
patients with advanced type III or IV hilar cholangiocarcinoma: a
percutaneous versus endoscopic approach. Gastrointest Endosc.
69:55–62. 2009. View Article : Google Scholar : PubMed/NCBI
|
15
|
Chang WH, Kortan P and Haber GB: Outcome
in patients with bifurcation tumors who undergo unilateral versus
bilateral hepatic duct drainage. Gastrointest Endosc. 47:354–362.
1998. View Article : Google Scholar : PubMed/NCBI
|
16
|
Costamagna G, Tringali A, Petruzziello L
and Spada C: Hilar tumours. Can J Gastroenterol. 18:451–454.
2004.
|
17
|
Deviere J, Baize M, de Toeuf J and Cremer
M: Long-term follow-up of patients with hilar malignant stricture
treated by endoscopic internal biliary drainage. Gastrointest
Endosc. 34:95–101. 1988. View Article : Google Scholar : PubMed/NCBI
|
18
|
Lee BH, Choe DH, Lee JH, Kim KH and Chin
SY: Metallic stents in malignant biliary obstruction, prospective
long-term clinical results. AJR Am J Roentgenol. 168:741–745. 1997.
View Article : Google Scholar : PubMed/NCBI
|
19
|
Shitara K, lshinguro A, Munakata M, Sakata
Y, Mizuno Y and Wada R: A case of advanced gastric cancer with
obstructive jaundice that responded to TS-1/CPT-11 combination
therapy after percutaneous transhepatic cholaugio drainage. Gan To
Kagaku Ryoho. 32:1465–1468. 2005.(In Japanese).
|
20
|
Matsui T, Kojima H, Kato J, et al: A case
report of unrectable gastrie cancer that responded to 5-FU plus
paelitaxel (FT) therapy. Gan To Kagaku Ryoho. 31:939–942. 2004.(In
Japanese).
|
21
|
van Delden OM and Laméris JS: Percutaneous
drainage and stenting for palliation of malignant bile duct
obstruction. Eur Radiol. 18:448–456. 2008.PubMed/NCBI
|
22
|
Dy SM, Harman SM, Braun UK, Howie LJ,
Harris PF and Jayes RL: To stent or not to stent: an evidence-based
approach to palliative procedures at the end of life. J Pain
Symptom Manage. 43:795–801. 2012. View Article : Google Scholar : PubMed/NCBI
|
23
|
Gong B, Pan Y and Hu B: Interventional
treatment of patients with hiar obstruction. J Hepatobiliary Surg.
11:323–324. 2003.
|